GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gracell Biotechnologies Inc (NAS:GRCL) » Definitions » PB Ratio

Gracell Biotechnologies (Gracell Biotechnologies) PB Ratio : 4.43 (As of Apr. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gracell Biotechnologies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), Gracell Biotechnologies's share price is $10.25. Gracell Biotechnologies's Book Value per Share for the quarter that ended in Sep. 2023 was $2.32. Hence, Gracell Biotechnologies's PB Ratio of today is 4.43.

The historical rank and industry rank for Gracell Biotechnologies's PB Ratio or its related term are showing as below:

GRCL' s PB Ratio Range Over the Past 10 Years
Min: 0.49   Med: 0.92   Max: 4.43
Current: 4.43

During the past 5 years, Gracell Biotechnologies's highest PB Ratio was 4.43. The lowest was 0.49. And the median was 0.92.

GRCL's PB Ratio is not ranked
in the Biotechnology industry.
Industry Median: 2.385 vs GRCL: 4.43

During the past 12 months, Gracell Biotechnologies's average Book Value Per Share Growth Rate was -27.90% per year.

Back to Basics: PB Ratio


Gracell Biotechnologies PB Ratio Historical Data

The historical data trend for Gracell Biotechnologies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gracell Biotechnologies PB Ratio Chart

Gracell Biotechnologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
- - - 1.42 0.79

Gracell Biotechnologies Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 0.79 0.72 1.64 1.24

Competitive Comparison of Gracell Biotechnologies's PB Ratio

For the Biotechnology subindustry, Gracell Biotechnologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gracell Biotechnologies's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gracell Biotechnologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where Gracell Biotechnologies's PB Ratio falls into.



Gracell Biotechnologies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Gracell Biotechnologies's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2023)
=10.25/2.316
=4.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Gracell Biotechnologies  (NAS:GRCL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Gracell Biotechnologies PB Ratio Related Terms

Thank you for viewing the detailed overview of Gracell Biotechnologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Gracell Biotechnologies (Gracell Biotechnologies) Business Description

Traded in Other Exchanges
N/A
Address
218 Sangtian Street, Building 12, Block B, Phase II, Biobay Industrial Park, Suzhou Industrial Park, Suzhou, CHN, 215123
Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer. The company aims to disrupt conventional approaches to CAR-T cell therapies with its proprietary technology platforms-FasTCAR and TruUCAR.

Gracell Biotechnologies (Gracell Biotechnologies) Headlines

From GuruFocus